Noncoding RNAs (ncRNAs) are crucial regulators in initiating and promoting thyroid cancer. Exploring the relationship between ncRNAs and thyroid cancer is essential for the diagnosis and treatment of thyroid cancer. Wet-lab experiments are costly and are difficult to conduct on a large scale. Although there are several ncRNA and cancer-related databases, there are few data related to thyroid cancer. There is a lack of computational approaches for predicting ncRNA-thyroid cancer associations. This work describes TCGCN, a linear residual graph convolution network to predict ncRNA-thyroid cancer associations. We collected a large amount of ncRNA-disease association data and constructed a bipartite graph. We use a simple linear embedding propagation at each convolutional layer and use the weighted sum of the embeddings on all graph convolutional layers to make the final prediction. In 5-fold cross-validation on the ncRNA-thyroid cancer dataset, TCGCN obtained significantly better performances with an AUC of 0.8162 and an AUPR of 0.8049, which are considerably better than those of other state-of-the-art approaches. We also demonstrate the usability of our method in the case studies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2022.105447DOI Listing

Publication Analysis

Top Keywords

thyroid cancer
20
ncrna-thyroid cancer
12
noncoding rnas
8
cancer
8
graph convolutional
8
cancer associations
8
thyroid
5
exploring noncoding
4
rnas thyroid
4
graph
4

Similar Publications

Comprehensive analysis of clinicopathologic and prognostic features in locally advanced thyroid papillary cancer.

Braz J Otorhinolaryngol

January 2025

Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Department of Head and Neck Surgery, Liaoning Province, China.

Objective: Differentiated thyroid cancers tend to excellent long-term survival after surgery. However, Locally Advanced Papillary Thyroid Cancers (LAPTCs) have poor prognosis. This study was to investigate the clinicopathologic features of LAPTC and the risk factors that affect its postoperative recurrence.

View Article and Find Full Text PDF

In this study, we identified cancer-associated fibroblast (CAF) molecular subtypes and developed a CAF-based prognostic model for breast cancer (BRCA). The heterogeneity of cancer-associated fibroblasts (CAFs) and their significant involvement in the advancement of BRCA were discovered employing single-cell RNA sequencing. Notably, we discovered that the RUNX1/SDC1 axis enhances BRCA cell invasion and metastasis.

View Article and Find Full Text PDF

Thyroid surgery under nerve auto-fluorescence & artificial intelligence tissue identification software guidance.

Langenbecks Arch Surg

January 2025

Department of General Surgery, Sanatorio Otamendi & Miroli (Otamendi & Miroli Hospital), University of Buenos Aires, Buenos Aires, Argentina.

Thyroid cancer is a common malignancy that requires comprehensive clinical evaluation prior to adequate surgical management. Over the last three decades thyroid surgery has tripled and is considered one of the most commonly performed procedures in general surgery. These procedures are associated with potential postoperative complications with significant deterioration in the patient's quality of life.

View Article and Find Full Text PDF

Autism spectrum disorder (ASD) is a pervasive neurobehavioral condition characterized by disruption of behavioral and emotional patterns in individuals with this condition. Given that various environmental and genetic factors play a fundamental role in the pathophysiology of ASD, it can be said that ASD is a multifaceted disease. This study used scientific databases including Google Scholar, PubMed, Scopus, and Semantic Scholar.

View Article and Find Full Text PDF

Background: Few studies have examined childbirth and adverse perinatal outcomes among male adolescents and young adults with cancer (AYAs, diagnosed at age 15-39 years). We conducted a population-based assessment of these outcomes in a large, diverse sample.

Methods: Male AYAs diagnosed between January 1, 1995 and December 31, 2015 were identified using the Texas Cancer Registry and linked to live birth certificates and the Texas Birth Defects Registry through December 31, 2016.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!